Kunshan, China

Baolei Tian

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Suzhou Ribo Life Science Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Baolei Tian. Retrieved from https://idiyas.com/inventor/baolei-tian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Baolei Tian: Innovator in Nucleic Acid Research

Introduction

Baolei Tian is a prominent inventor based in Kunshan, China. He has made significant contributions to the field of nucleic acid research, particularly in the development of pharmaceutical compositions and conjugates. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing scientific knowledge.

Latest Patents

Baolei Tian holds a patent titled "Nucleic Acid, Pharmaceutical Composition, Conjugate, Preparation Method, and Use." This patent reflects his commitment to exploring new methodologies and applications in the realm of pharmaceuticals. With 1 patent to his name, he continues to push the boundaries of what is possible in his field.

Career Highlights

Throughout his career, Baolei Tian has been associated with Suzhou Ribo Life Science Co., Ltd., where he has collaborated with other talented professionals. His work at this company has allowed him to focus on innovative research and development, contributing to the advancement of life sciences.

Collaborations

Baolei Tian has worked alongside notable colleagues such as Shan Gao and Daiwu Kang. Their collaborative efforts have fostered a dynamic research environment, leading to groundbreaking discoveries and advancements in their respective fields.

Conclusion

Baolei Tian is a dedicated inventor whose work in nucleic acid research has the potential to impact the pharmaceutical industry significantly. His innovative spirit and collaborative approach continue to drive progress in scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…